BeiGene
BGNE
#963
Rank
C$28.77 B
Marketcap
$253.60
Share price
1.02%
Change (1 day)
7.80%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Number of shares outstanding for BeiGene (BGNE)

Number of shares outstanding as of December 2024 : 105,903,990

According to BeiGene 's latest financial reports and stock price the company's current number of shares outstanding is 105,903,990. At the end of 2024 the company had 105,903,990 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for BeiGene from 2015 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20240.10 B1.18%
20230.10 B0.87%
20220.10 B9.19%
202195.02 M4.6%
202090.84 M49.7%
201960.68 M2.19%
201859.38 M30.39%
201745.54 M14.78%
201639.67 M25.9%
201531.51 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
21,043,458-80.13%๐Ÿ‡บ๐Ÿ‡ธ USA
694,622,466 555.90%๐Ÿ‡บ๐Ÿ‡ธ USA